Abbott Laboratories (ABT)

Investing Cash Flow

-$22.37B

TTM · Period ending: · USD

ABT logo

ABT Investing Cash Flow

Latest reported-$22.37B
ABT TTM Cash from Investing (-$618.30M → -$22.37B)
High-resolution chart · PNG

ABT investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Abbott Laboratories Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-22,367,000,000
-22,276,000,000
-2,422,000,000
-2,375,000,000
-2,512,000,000
-2,383,000,000
-2,338,000,000
-2,296,000,000
-2,336,000,000
-3,096,000,000
-3,133,000,000
-2,941,000,000
-2,791,000,000
-1,842,000,000
-1,740,000,000
-1,779,000,000
-1,946,000,000
-1,946,000,000
-2,008,000,000
-2,068,000,000
-1,889,000,000
-2,244,000,000
-2,215,000,000
-1,973,000,000
-1,933,000,000
-1,812,000,000
-1,815,000,000
-1,822,000,000
-1,713,000,000
-1,514,000,000
-1,356,000,000
-4,012,000,000
-3,995,000,000
-3,702,000,000
-9,618,000,000
-4,916,000,000
-5,164,000,000
-6,628,000,000
-248,000,000
-232,000,000
-875,000,000
837,000,000
406,000,000
-1,170,000,000
-798,000,000
188,000,000
-202,000,000
647,703,000
-1,224,063,000
-2,415,989,000
-3,929,000,000
-5,994,140,000
-3,828,981,000
-3,176,685,000
-6,081,288,000
-3,491,377,000
-1,967,775,000
-2,450,552,000
260,832,000
-3,544,031,000
-6,929,024,000
-6,830,785,000
-12,188,315,000
-8,185,049,000
-7,310,488,000
-9,751,712,000
-3,698,710,000
-5,613,772,000
-4,149,434,000
-2,800,084,000
-2,087,491,000
-1,963,668,000
-2,267,845,000
-1,640,462,000
-1,136,277,000
-4,828,475,000
-4,834,782,000
-11,494,279,000
-11,397,629,000
-8,038,709,000
-7,956,890,000
-1,403,221,000
-720,087,000
-538,117,000
-525,552,000
-2,222,761,000
-3,923,390,000
-4,090,622,000
-4,290,352,000
-2,672,040,000
-1,630,605,000
-1,442,983,000
-1,315,199,000
-1,854,204,000
-1,881,620,000
-2,117,716,000
-2,366,705,000
-3,064,392,000
-8,384,874,000
-8,029,661,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.